Dr. Sulaiman Al Habib Reports SAR 503.29M Net Profit in Q1 2026
SULAIMAN ALHABIB 4013.SA | 0.00 |
On 2026-05-03 08:00:24 (Saudi Time), Dr. Sulaiman Al Habib Medical Services Group announced its Interim financial results for the three months ended on March 31, 2026.
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 3,435.76 | 3,157.78 | 8.803 | 3,701.45 | -7.177 |
| Gross Profit (Loss) | 955.97 | 1,028.31 | -7.034 | 1,062.78 | -10.05 |
| Operational Profit (Loss) | 587.75 | 625.93 | -6.099 | 682.48 | -13.88 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 503.29 | 557.01 | -9.644 | 651.16 | -22.708 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 506.47 | 546.5 | -7.324 | 640.86 | -20.97 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Total Shareholders Equity (after Deducting Minority Equity) | 7,949.69 | 7,291.14 | 9.032 |
| Profit (Loss) per Share | 1.44 | 1.59 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
Year-on-Year Performance Drivers
Sales increased 8.803% YoY to SAR 3,435.76 million, driven by growth across all operating segments including hospitals, pharmacies, and solutions, supported by higher patient volumes and new hospital expansions that added 2,000 beds during 2024-2025. Net profit declined 9.644% YoY to SAR 503.29 million despite revenue growth, primarily due to fixed costs associated with strategic expansions including higher depreciation and financing costs from newly commissioned hospitals still in ramp-up phase. The profitability impact was further affected by seasonal factors in Q1, though EBITDA increased 4.59% indicating underlying operational strength.
Quarter-on-Quarter Performance Drivers
QoQ revenue declined 7.177% to SAR 3,435.76 million due to seasonal factors affecting revenue levels between quarters. Net profit dropped 22.708% to SAR 503.29 million, primarily driven by seasonal factors impacting revenue growth and fixed costs from new hospital expansions still in ramp-up phase. The newly opened hospitals with 2,000 additional beds are gradually increasing their contribution as they approach optimal operating levels.
Other Items
The auditors issued an unmodified conclusion with no additional comments, disclaimers, or adverse opinions noted. Dr. Sulaiman Al Habib Medical Services Group reported Q1 2026 results showing revenue of SAR 3,435.76 million with net profit of SAR 503.29 million and earnings per share of SAR 1.44. Total shareholders equity increased 9.032% to SAR 7,949.69 million. The company stated that "these newly commissioned hospitals are currently in the ramp-up phase, and increasing their contribution to revenue until they reach their optimal operating levels" regarding its expansion strategy that added 2,000 beds across multiple facilities.
Original announcement:
https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=94861&anCat=1&cs=4013&locale=arAttached PDF document link:
https://www.saudiexchange.sa/Resources/fsPdf/8578_1601_2026-05-02_16-21-23_en.pdfImportant Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.